Tower Research Capital (TRC)’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Tower Research Capital (TRC)’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,508	Closed	-$329K	–	5312
2020 Q2	$329K	Buy	+5,508	New	+$340K	0.01%	1366
2020 Q1	–	Sell	-3,674	Closed	-$201K	–	4374
2019 Q4	$201K	Buy	3,674 +2,930	+394%	+$109K	0.02%	578
2019 Q3	$21K	Sell	744 -1,388	-65%	-$50.9K	﹤0.01%	2462
2019 Q2	$71K	Buy	2,132 +2,019	+1,787%	+$63K	﹤0.01%	1375
2019 Q1	$4K	Sell	113 -142	-56%	-$4.52K	﹤0.01%	3241
2018 Q4	$7K	Buy	+255	New	+$6.57K	﹤0.01%	2747

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Tower Research Capital (TRC)'s PRNB Position: Q3 2020 in Review

Tower Research Capital (TRC) sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 5,508 shares — an estimated $329K sold.

Tower Research Capital (TRC) first reported a position in PRNB in Q4 2018 and held it in 6 quarters. The position peaked at $329K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Tower Research Capital (TRC) reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,508 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $329K.
Tower Research Capital (TRC) first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Tower Research Capital (TRC)'s Principia Biopharma Inc. Common Stock position peaked at $329K in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.